Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 157 (1) , 280-286
Abstract
No abstract availableKeywords
Funding Information
- Ambry Genetics
This publication has 37 references indexed in Scilit:
- The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicineAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2018
- Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancerFamilial Cancer, 2016
- Models of Service Delivery for Cancer Genetic Risk Assessment and CounselingJournal of Genetic Counseling, 2013
- Genetic Risk Assessment for Women with Epithelial Ovarian Cancer: Referral Patterns and Outcomes in a University Gynecologic Oncology ClinicJournal of Genetic Counseling, 2013
- Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancerFamilial Cancer, 2008
- Increasing Utilization of Cancer Genetic Counseling Services Using a Patient Navigator ModelJournal of Genetic Counseling, 2007
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- The frequency of founder mutations in theBRCA1,BRCA2, andAPC genes in australian Ashkenazi JewsCancer, 2001
- BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian CancerThe American Journal of Human Genetics, 2000
- The Prevalence of Common BRCA1 and BRCA2 Mutations among Ashkenazi JewsThe American Journal of Human Genetics, 1999